Roche
Foundation Medicine, Syndax Pharmaceuticals Partner to Develop CDx for AML Treatment
The companion diagnostic assay, for a drug under development by Syndax, will identify acute myeloid leukemia patients with an NPM1 mutation.
Roche Invests RMB 3B to Expand Chinese Diagnostics Facility
The production facility focuses on the manufacturing of diagnostic products mainly for China and parts of Asia-Pacific.
At the ADLM annual meeting, firms said they see game-changing opportunities for platforms that provide the right combination of clinical utility and convenience.
Roche Diagnostics Base Business Grows 9 Percent in First Half of 2024, Firm Raises FY24 Outlook
The firm's overall sales were nearly flat year over year, although at constant exchange rates sales increased 5 percent.
May 22, 2024
May 22, 2024
May 1, 2024